发明名称 Evaluative means for detecting inflammatory reactivity
摘要 Inbred Lewis (LEW/N) female rats develop an arthritis in response to Group A streptococcal cell wall peptidoglycanpolysaccharide (SCW) which mimics human rheumatoid arthritis. Histocompatible Fischer (F344/N) rats, on the other hand, do not develop arthritis in response to the same SCW stimulus. To evaluate this difference in inflammatory reactivity between the two strains, the function of the hypothalamic-pituitary-adrenal axis and its ability to modulate the development of the inflammatory response was studied. It has been found that, in contrast to F344/N rats, LEW/N rats had markedly impaired plasma ACTH and corticosterone responses to SCW, recombinant human Interleukin-1 alpha (IL-1 alpha), the serotonin agonist, quipazine, and synthetic rat corticotropin-releasing hormone (CRH). In addition, LEW/N rats compared to F344/N rats had smaller adrenal glands and larger thymuses. Treatment of LEW/N rats with replacement doses of dexamethasone decreased the severity of their SCW-induced arthritis. Conversely, treatment of F344/N rats with the glucocorticoid receptor antagonist, RU 486, or the serotonin (5-HT2) antagonist, LY53857, was associated with development of severe inflammatory disease, including arthritis, in response to SCW. These findings support the concept that susceptibility of LEW/N rats to SCW arthritis is related to abnormal hypothalamic-pituitary-adrenal (HPA) axis responsiveness to inflammatory and other stress mediators and that resistance of F344/N rats to SCW arthritis is regulated by an intact HPA axis-immune system feedback loop.
申请公布号 US5209920(A) 申请公布日期 1993.05.11
申请号 US19890412294 申请日期 1989.09.25
申请人 THE UNITED STATES OF AMERICA AS REPRESENTED BY THE UNITED STATES DEPARTMENT OF HEALTH AND HUMAN SERVICES 发明人 STERNBERG, ESTHER M.;WILDER, RONALD L.;GOLD, PHILIP W.;CHROUSOS, GEORGE P.
分类号 A61K31/135;A61K31/35;A61K31/365;A61K31/40;A61K31/485;A61K31/495;A61K31/565;A61K31/57;A61K31/585;A61K38/22;A61K45/06;G01N33/50;G01N33/564;G01N33/74 主分类号 A61K31/135
代理机构 代理人
主权项
地址